Smith & Nephew PLC (SNN)

44.89 -0.99  -2.16% NYSE Jan 21, 20:00 USD
View Full Chart
Price Chart
View All SNN News

News

View All Events

Events

Date Type Description
07/29/2021 Misc Smith & Nephew PLC Second Quarter Earnings Conference Call for 2021
02/19/2021 Earnings Smith & Nephew PLC Fourth Quarter Earnings Results for 2020
10/01/2020 Dividends Amount: 0.288, Declared Date: Jul 29 2020, Pay Date: Oct 28 2020
07/29/2020 15:30 EDT Misc Smith & Nephew PLC Second Quarter Earnings Conference Call for 2020
07/29/2020 14:00 EDT Earnings Smith & Nephew PLC Second Quarter Earnings Results for 2020
04/09/2020 14:00 GMT Misc Smith & Nephew PLC Annual General Meeting for 2019
04/02/2020 Dividends Amount: 0.462, Declared Date: Feb 21 2020, Pay Date: May 06 2020
03/02/2020 Misc Smith & Nephew PLC Annual Report for 2019
02/20/2020 Earnings Smith & Nephew PLC Fourth Quarter Earnings Results for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.smith-nephew.com
  • Investor Relations URL: http://www.smith-nephew.com/investor-centre/
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Medical Devices
  • Equity Style: Large Cap/Blend
  • Next Earnings Release: Feb. 19, 2021
  • Last Earnings Release: Jul. 29, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Oct. 01, 2020
  • Description: Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and ENT technologies, and wound-care solutions. Slightly more than 40% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 27% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Top Fund Holders

Symbol Name Weighting
NCLIX Nuance Concentrated Value L-S Invt 5.03%
NCAVX Nuance Concentrated Value Investor 4.75%
NMAVX Nuance Mid Cap Value Investor 3.78%
TPICX Timothy Plan International C 2.02%
F00000XK9F JNL Multi-Manager Mid Cap A 0.83%
TSGUX Morgan Stanley Pathway Sm-Mid Cap Eq 0.45%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.